Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammasomes and rheumatic diseases: evolving concepts.

P I Sidiropoulos1, G Goulielmos, G K Voloudakis

  • 1Department of Rheumatology, Clinical Immunology and Allergy, University Hospital, Medical School, University of Crete, Heraklion, Greece. sidiropp@med.uoc.gr

Annals of the Rheumatic Diseases
|October 9, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atmospheric Pressure Plasma Functionalization of Sealed PDMS Microfluidics: Application to Capillary Pumping and Enhanced Cell Growth.

ChemPlusChem·2024
Same author

Regional European genetic ancestry predicts type I interferon level and risk of severe viral infection.

QJM : monthly journal of the Association of Physicians·2024
Same author

Primary adrenal insufficiency due to bilateral adrenal hemorrhage-adrenal infarction in a patient with systemic lupus erythematosus and antiphospholipid syndrome: case presentation and review of the literature.

Hormones (Athens, Greece)·2023
Same author

Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the 'Attikon' cohort.

Lupus·2020
Same author

Regional cerebral perfusion correlates with anxiety in neuropsychiatric SLE: evidence for a mechanism distinct from depression.

Lupus·2019
Same author

Is systemic lupus erythematosus different in urban versus rural living environment? Data from the Cretan Lupus Epidemiology and Surveillance Registry.

Lupus·2018
Same journal

Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups.

Annals of the rheumatic diseases·2026
Same journal

A data-driven, weighted flare score that accurately predicts organ damage in systemic lupus erythematosus.

Annals of the rheumatic diseases·2026
Same journal

PD-1 signalling restrains pathogenic T peripheral helper and effector CD4⁺ T cell functions in rheumatoid arthritis.

Annals of the rheumatic diseases·2026
Same journal

Remission of refractory lupus nephritis is temporally associated with antitumour therapy, including durvalumab for endometrial carcinoma.

Annals of the rheumatic diseases·2026
Same journal

Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project.

Annals of the rheumatic diseases·2026
Same journal

Commentary on 'Assessing the performance of AI chatbots in answering patients common questions about low back pain'.

Annals of the rheumatic diseases·2026
See all related articles

Innate immunity, specifically nucleotide-binding and oligomerisation domain (NOD)-like receptors (NLRs) and inflammasomes, plays a key role in inflammatory rheumatic diseases. Targeting these pathways offers potential therapeutic strategies for conditions like rheumatoid arthritis and gout.

Area of Science:

  • Immunology
  • Rheumatology
  • Molecular Biology

Background:

  • Inflammatory rheumatic diseases involve cytokine production triggered by endogenous signals.
  • Innate immunity mechanisms are increasingly recognized for their role in disease pathogenesis.
  • Nucleotide-binding and oligomerisation domain (NOD)-like receptors (NLRs) are key sensors in innate immunity.

Purpose of the Study:

  • To explore the role of NLRs and inflammasomes in the pathogenesis of inflammatory rheumatic diseases.
  • To understand how NLRs contribute to the initiation and progression of inflammation in rheumatic conditions.
  • To identify inflammasome pathways as potential therapeutic targets.

Main Methods:

  • Review of recent data on NLRs and inflammasome complexes.

Related Experiment Videos

  • Analysis of inflammasome components: NLR sensor, ASC adaptor, and caspase effector.
  • Investigation of inflammasome activation leading to pro-inflammatory cytokine release (IL-1β, IL-18).

    • Main Results:

    • NLRs are implicated in sensing cellular damage and endogenous metabolites.
    • Inflammasomes, comprising NLRs, ASC, and caspases, activate key inflammatory cytokines.
    • Evidence suggests inflammasome involvement in autoinflammatory and rheumatic diseases like rheumatoid arthritis and gout.

    Conclusions:

    • The inflammasome pathway is a significant contributor to the pathogenesis of inflammatory rheumatic diseases.
    • Targeting NLRs and inflammasome signaling presents a promising therapeutic avenue.
    • Further research into these innate immunity pathways could lead to novel treatments for rheumatic conditions.